Genelink Inc (GNLKQ)
0.00
USD |
OTCM |
Nov 13, 16:00
Genelink Total Assets (Quarterly): 1.284M for Sept. 30, 2013
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2013 | 1.284M |
June 30, 2013 | 1.273M |
March 31, 2013 | 1.236M |
December 31, 2012 | 1.455M |
September 30, 2012 | 2.698M |
June 30, 2012 | 2.124M |
March 31, 2012 | 2.654M |
December 31, 2011 | 2.780M |
September 30, 2011 | 2.13M |
June 30, 2011 | 1.818M |
March 31, 2011 | 1.674M |
December 31, 2010 | 1.721M |
September 30, 2010 | 1.736M |
June 30, 2010 | 1.858M |
March 31, 2010 | 1.823M |
December 31, 2009 | 1.881M |
September 30, 2009 | 2.136M |
June 30, 2009 | 2.247M |
March 31, 2009 | 2.743M |
December 31, 2008 | 2.545M |
September 30, 2008 | 3.772M |
June 30, 2008 | 1.926M |
March 31, 2008 | 1.015M |
December 31, 2007 | 1.384M |
September 30, 2007 | 0.58M |
Date | Value |
---|---|
June 30, 2007 | 0.5875M |
March 31, 2007 | 0.6252M |
December 31, 2006 | 0.5485M |
September 30, 2006 | 0.5476M |
June 30, 2006 | 0.627M |
March 31, 2006 | 0.4613M |
December 31, 2005 | 0.4453M |
September 30, 2005 | 0.5565M |
June 30, 2005 | 0.5436M |
March 31, 2005 | 0.4948M |
December 31, 2004 | 0.5653M |
September 30, 2004 | 0.5675M |
June 30, 2004 | 0.515M |
March 31, 2004 | 0.7417M |
December 31, 2003 | 1.212M |
September 30, 2003 | 0.3972M |
June 30, 2003 | 0.2808M |
March 31, 2003 | 0.2993M |
December 31, 2002 | 0.3191M |
September 30, 2002 | 0.5635M |
June 30, 2002 | 0.3951M |
March 31, 2002 | 0.5021M |
December 31, 2001 | 0.3654M |
September 30, 2001 | 0.1295M |
June 30, 2001 | 0.1099M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 24.07M |
AIM ImmunoTech Inc | 15.72M |
IGC Pharma Inc | 10.59M |
NovaBay Pharmaceuticals Inc | 3.925M |
Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.488M |
Shareholders Equity (Quarterly) | -3.203M |